NPLOC4
Nuclear protein localization protein 4 homolog
Also known as: FLJ20657, KIAA1499, NPL4, NPL4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TAT6
- Gene
- NPLOC4
- Ensembl
- ENSG00000182446
- Chromosome
- 17
- Canonical length
- 608 aa
- Protein class
- Predicted intracellular proteins, Transporters
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
Predicted to enable ubiquitin binding activity and ubiquitin protein ligase binding activity. Predicted to contribute to K48-linked polyubiquitin modification-dependent protein binding activity and K63-linked polyubiquitin modification-dependent protein binding activity. Involved in negative regulation of RIG-I signaling pathway; negative regulation of type I interferon production; and proteolysis involved in protein catabolic process. Located in nucleus. Part of UFD1-NPL4 complex and VCP-NPL4-UFD1 AAA ATPase complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
608 residues, UniProt reviewed canonical sequence.
>Q8TAT6|NPLOC4
1 MAESIIIRVQ SPDGVKRITA TKRETAATFL KKVAKEFGFQ NNGFSVYINR NKTGEITASS
61 NKSLNLLKIK HGDLLFLFPS SLAGPSSEME TSVPPGFKVF GAPNVVEDEI DQYLSKQDGK
121 IYRSRDPQLC RHGPLGKCVH CVPLEPFDED YLNHLEPPVK HMSFHAYIRK LTGGADKGKF
181 VALENISCKI KSGCEGHLPW PNGICTKCQP SAITLNRQKY RHVDNIMFEN HTVADRFLDF
241 WRKTGNQHFG YLYGRYTEHK DIPLGIRAEV AAIYEPPQIG TQNSLELLED PKAEVVDEIA
301 AKLGLRKVGW IFTDLVSEDT RKGTVRYSRN KDTYFLSSEE CITAGDFQNK HPNMCRLSPD
361 GHFGSKFVTA VATGGPDNQV HFEGYQVSNQ CMALVRDECL LPCKDAPELG YAKESSSEQY
421 VPDVFYKDVD KFGNEITQLA RPLPVEYLII DITTTFPKDP VYTFSISQNP FPIENRDVLG
481 ETQDFHSLAT YLSQNTSSVF LDTISDFHLL LFLVTNEVMP LQDSISLLLE AVRTRNEELA
541 QTWKRSEQWA TIEQLCSTVG GQLPGLHEYG AVGGSTHTAT AAMWACQHCT FMNQPGTGHC
601 EMCSLPRTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NPLOC4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 156 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 156 nTPM
- heart muscle: 56 nTPM
- liver: 53 nTPM
- tongue: 52 nTPM
- esophagus: 50 nTPM
- blood vessel: 47 nTPM
Single-cell type
- myonuclei: 222 nCPM
- esophageal apical cells: 194 nCPM
- retinal ganglion cells: 170 nCPM
- proximal tubule cells: 160 nCPM
- endometrial glandular cells: 159 nCPM
- retinal pigment epithelial cells: 154 nCPM
Immune cell
- classical monocyte: 20 nTPM
- total PBMC: 9.9 nTPM
- myeloid DC: 6.3 nTPM
- neutrophil: 5.3 nTPM
- intermediate monocyte: 4.8 nTPM
- plasmacytoid DC: 4.7 nTPM
Brain region
- medulla oblongata: 79 nTPM
- hypothalamus: 78 nTPM
- cerebral cortex: 77 nTPM
- white matter: 76 nTPM
- pons: 74 nTPM
- thalamus: 73 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.13
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.2
- DepMap mean gene effect
- -1.39
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- ERAD pathway
- Golgi organization
- negative regulation of RIG-I signaling pathway
- negative regulation of type I interferon production
- proteasome-mediated ubiquitin-dependent protein catabolic process
- retrograde protein transport, ER to cytosol
- ubiquitin-dependent protein catabolic process
Molecular functions
- ATPase binding
- K48-linked polyubiquitin modification-dependent protein binding
- K63-linked polyubiquitin modification-dependent protein binding
- protein-containing complex binding
- ubiquitin binding
- ubiquitin protein ligase binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Zinc finger, RanBP2-type
- Ubiquitin-like domain superfamily
- Zinc finger, RanBP2-type superfamily
- MPN domain
- NPL4, zinc-binding putative
- Nuclear pore localisation protein NPL4, C-terminal
- Nuclear protein localization protein 4
- Nuclear pore localisation protein Npl4, ubiquitin-like domain
- NPL4 family, putative zinc binding region
- NPL4 family
- Nuclear pore localisation protein NPL4
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NPLOC4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NPLOC4 as an antibody target. Whether an autoantibody or antibody against NPLOC4 could matter depends on whether native NPLOC4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NPLOC4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NPLOC4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...